In a study published in the journal Physics in Medicine and Biology, researchers investigated the impact of ultra-high dose rate radiotherapy, known as FLASH, on normal and tumor tissue cell killing. It has been suggested that FLASH reduces normal tissue toxicities by depleting them of oxygen. The survival of both normal tissue and cancer cells after radiotherapy depends on the dose and oxygen levels, with even a small fraction of tissue at low oxygen levels having a significant effect on the response to treatment. To understand the effects of FLASH on radiation-induced cell killing, the researchers simulated oxygen diffusion, metabolism, and radiolytic oxygen depletion in domains with simulated capillary architectures. They used two architectural models: randomly distributed capillaries and capillaries forming a regular square lattice array. The resulting distribution histograms of oxygen partial pressure were then used to simulate cell survival in normal and tumor tissues using the linear quadratic model of cell survival. The findings showed that FLASH increased tumor cell survival compared to conventional radiotherapy. The magnitude of this increase depended on the expected levels of tumor hypoxia relative to radiolytic oxygen depletion and tissue oxygen metabolism. Interestingly, for the random capillary model, FLASH had a much greater impact on well-oxygenated (normal) tissues. It was estimated that there could be an increase in cell survival by up to 10 orders of magnitude in these tissues, despite only modest reductions in mean tissue partial pressure (less than 7 mmHg for the studied parameters). The presence of very small nearly hypoxic regions within otherwise well-perfused normal tissues with high mean oxygen levels resulted in a greater sparing of normal tissue compared to tumor cells during FLASH irradiation. This observation may help explain empirical results showing normal tissue sparing and iso-tumor control. Overall, this study provides insights into how spatial oxygen heterogeneity can affect radiolytic oxygen depletion during FLASH radiotherapy. The findings highlight the potential benefits of FLASH in reducing normal tissue toxicities and improving tumor cell survival, particularly in well-oxygenated tissues.
FLASH radiotherapy is a special kind of treatment that uses very fast radiation to kill cancer cells. It can also protect normal tissues by taking away their oxygen. The amount of radiation and the level of oxygen in the body affect how well both cancer cells and normal tissues survive after treatment. FLASH radiotherapy helps cancer cells survive more than regular radiotherapy. It has a bigger effect on normal tissues with lots of oxygen compared to tumor cells. Even small decreases in oxygen levels can help normal tissues survive better during FLASH treatment. Having some areas with less oxygen in normal tissues can protect them more than tumor cells during FLASH treatment. The way oxygen is spread out in the body can affect how well FLASH radiotherapy works. FLASH has the potential to make treatment safer for normal tissues and improve survival for cancer cells, especially in well-oxygenated tissues."
Definitions
- Radiotherapy: A type of treatment that uses radiation to kill cancer cells.
- Toxicities: Harmful effects or damage caused by something.
- Depleting: Using up or reducing something completely.
- Survival: How long something or someone can stay alive.
- Conventional: Usual or typical way of doing something.
- Tumor: A mass or lump formed by abnormal cell growth, which can be cancerous.
- Capillary: Tiny blood vessels that carry blood between larger blood vessels and body tissue.
- Irradiation: The process of exposing something to radiation.
- Heterogeneity
Exploring the Impact of Ultra-High Dose Rate Radiotherapy on Normal and Tumor Tissue Cell Killing
Radiotherapy is a common form of cancer treatment, but it can cause damage to normal tissue. To reduce this risk, researchers have been investigating the potential benefits of ultra-high dose rate radiotherapy (FLASH). In a study published in the journal Physics in Medicine and Biology, researchers investigated how FLASH affects radiation-induced cell killing in both normal and tumor tissues.
Simulating Oxygen Diffusion, Metabolism, and Radiolytic Oxygen Depletion
The survival of both normal tissue and cancer cells after radiotherapy depends on the dose and oxygen levels. To understand how FLASH affects cell survival, the researchers simulated oxygen diffusion, metabolism, and radiolytic oxygen depletion in domains with simulated capillary architectures. They used two architectural models: randomly distributed capillaries and capillaries forming a regular square lattice array. The resulting distribution histograms of oxygen partial pressure were then used to simulate cell survival in normal and tumor tissues using the linear quadratic model of cell survival.
Findings Show Increased Tumor Cell Survival with FLASH
The findings showed that FLASH increased tumor cell survival compared to conventional radiotherapy. The magnitude of this increase depended on the expected levels of tumor hypoxia relative to radiolytic oxygen depletion and tissue oxygen metabolism. Interestingly, for the random capillary model, FLASH had a much greater impact on well-oxygenated (normal) tissues than it did on tumors. It was estimated that there could be an increase in cell survival by up to 10 orders of magnitude in these tissues despite only modest reductions in mean tissue partial pressure (less than 7 mmHg for the studied parameters). This observation may help explain empirical results showing normal tissue sparing during FLASH irradiation as well as iso-tumor control – meaning that tumors are controlled without additional damage to surrounding healthy tissue.
Conclusion
Overall, this study provides insights into how spatial oxygen heterogeneity can affect radiolytic oxygen depletion during FLASH radiotherapy. The findings highlight the potential benefits of FLASH in reducing normal tissue toxicities while improving tumor cell survival – particularly when applied to well-oxygenated tissues – which could lead to improved patient outcomes following cancer treatments involving radiation therapy.
It has been postulated that the delivery of radiotherapy at ultra-high dose rates ("FLASH") reduces normal tissue toxicities by depleting them of oxygen. The fraction of normal tissue and cancer cells surviving radiotherapy depends on dose and oxygen levels in an exponential manner and even a very small fraction of tissue at low oxygen levels can determine radiotherapy response. The effect of FLASH on radiation-induced normal and tumour tissue cell killing was studied by simulating oxygen diffusion, metabolism, and radiolytic oxygen depletion over domains with simulated capillary architectures. Two architectural models were used: 1.) randomly distributed capillaries and 2.) capillaries forming a regular square lattice array. The resulting oxygen partial pressure distribution histograms were used to simulate normal and tumour tissue cell survival using the linear quadratic model of cell survival, modified to incorporate oxygen-enhancement ratio (OER) effects. Tumour cell survival was found to be increased by FLASH as compared to conventional radiotherapy, with a 0-1 order of magnitude increase for expected levels of tumour hypoxia, depending on the relative magnitudes of radiolytic oxygen depletion and tissue oxygen metabolism. Interestingly, for the random capillary model, the impact of FLASH on well-oxygenated (normal) tissues was found to be much greater, with an estimated increase in cell survival by up to 10 orders of magnitude, even though reductions in mean tissue partial pressure were modest, less than 7 mmHg for the parameter values studied. The presence of very small nearly hypoxic regions in otherwise well-perfused normal tissues with high mean oxygen levels resulted in a greater proportional sparing of normal tissue than tumour cells during FLASH irradiation, possibly explaining empirical normal tissue sparing and iso-tumour control results.
